Work

Savings Across Drugs Under the GENEROUS Model in the US Medicaid Program

Year: 2026

Type: article

Abstract: This economic evaluation examines which drugs and therapeutic classes contribute to the most savings in the Generating Cost Reductions for US Medicaid model inclusive of statutory and supplemental rebates.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2026.3983

Authors: Jeromie Ballreich, Nathan Jibat, Tucker Desmond, Joseph Levy

Institution: Johns Hopkins University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000

OpenAlex ID: W7223410571

FWCI:

Cites: 3

Cited by:

Related to: 10